| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| SAPERSTEIN ANDREW M | Co-President | C/O MORGAN STANLEY, 1585 BROADWAY, NEW YORK | /s/ Martin M. Cohen, Attorney-in-Fact | 18 Jul 2025 | 0001362383 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MS | Common Stock | Sale | -$3.12M | -22.2K | -50.97% | $140.68 | 21.4K | 17 Jul 2025 | By Grantor Retained Annuity Trust | F1, F2 |
| transaction | MS | Common Stock | Sale | -$3.02M | -21.4K | -100% | $141.28 | 0 | 17 Jul 2025 | By Grantor Retained Annuity Trust | F3 |
| holding | MS | Common Stock | 294K | 17 Jul 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.01 to $141.00, inclusive. The Reporting Person undertakes to provide to Morgan Stanley, any security holder of Morgan Stanley, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | Since the Reporting Person's last report, 43,566 shares of Common Stock previously reported as directly beneficially owned were contributed to a grantor retained annuity trust. |
| F3 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $141.01 to $141.68, inclusive. The Reporting Person undertakes to provide to Morgan Stanley, any security holder of Morgan Stanley, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |